Weight Loss Drug Users Flock to Social Media for Support

Two-thirds of individuals using popular GLP-1 weight loss medications are relying on social media for advice, feeling a significant lack of day-to-day support between clinical appointments. New research indicates that nearly three-quarters of UK-based GLP-1 users find it challenging to manage their treatment and track progress independently. Consequently, 65% are seeking reassurance and guidance on social media platforms.

Despite clinicians warning against social media as a substitute for medical advice, 90% of users report trusting GLP-1 information found online. This reliance is concerning, as online content can be incomplete or misleading, particularly regarding side effects and safe usage. Many users employ informal tracking methods like calendar reminders or notepads, which have proven unreliable, leading to missed or delayed doses for over half of them.

To address this support gap, Phlo has launched BrightTrack, a tool designed to help GLP-1 users track doses, monitor symptoms, and understand progress. This platform aims to consolidate key health data, enabling users to identify patterns, build consistent routines, and feel more confident in managing their treatment effectively, thereby bridging the disconnect between appointments.